1 |
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307: 1915-1920.
DOI
|
2 |
Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbiol. 4: 430-435.
DOI
|
3 |
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7: 335-336.
DOI
|
4 |
Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, et al. 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135: 1984-1992.
DOI
|
5 |
Das R, Feuerstadt P, Brandt LJ. 2010. Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with Clostridium difficile-associated disease. Am. J. Gastroenterol. 105: 2040-2049.
DOI
|
6 |
Kachrimanidou M, Malisiovas N. 2011. Clostridium difficile infection: a comprehensive review. Crit. Rev. Microbiol. 37: 178-187.
DOI
|
7 |
De Cruz P, Kang S, Wagner J, Buckley M, Sim WH, Prideaux L, et al. 2015. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study. J. Gastroenterol. Hepatol. 30: 268-278.
DOI
|
8 |
De La Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Dore J. 2005. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J. Clin. Microbiol. 43: 5588-5592.
DOI
|
9 |
Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194-2200.
DOI
|
10 |
Kelly CP. 2012. Current strategies for management of initial Clostridium difficile infection. J. Hosp. Med. 7: S5-S10.
DOI
|
11 |
Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, et al. 2008 Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 46: 431-437.
DOI
|
12 |
Kim HB, Borewicz K, White BA, Singer RS, Sreevatsan S, Tu ZJ, et al. 2012. Microbial shifts in the swine distal gut in response to the treatment with antimicrobial growth promoter, tylosin. Proc. Natl. Acad. Sci. USA 109: 15485-15490.
DOI
|
13 |
Kim HB, Isaacson RE. 2015. The pig gut microbial diversity: understanding the pig gut microbial ecology through the next generation high throughput sequencing. Vet. Microbiol. 177: 242-251.
DOI
|
14 |
Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. 2008. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin. Infect. Dis. 46: S19-S31.
DOI
|
15 |
Perez J, Springthorpe VS, Sattar SA. 2011. Clospore: a liquid medium for producing high titers of semi-purified spores of Clostridium difficile. J. AOAC Int. 94: 618-626.
|
16 |
Kim HB, Zhang Q, Sun X, Beamer G, Wang Y, Tzipori S. 2014. Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets. Antimicrob. Agents Chemother. 58: 7560-7564.
DOI
|
17 |
Lode H, Von der Hoh N, Ziege S, Borner K, Nord CE. 2001. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand. J. Infect. Dis. 33: 899-903.
DOI
|
18 |
Renggaman A, Choi HL, Sudiarto SI, Alasaarela L, Nam OS. 2015. Development of pig welfare assessment protocol integrating animal-, environment-, and management-based measures. J. Anim. Sci. Technol. 57: 1.
DOI
|
19 |
Riboulet-Bisson E, Sturme MH, Jeffery IB, O’Donnell MM, Neville BA, Forde BM, et al. 2012. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One 7: e31113.
DOI
|
20 |
Schloss PD, Larget BR, Handelsman J. 2004. Integration of microbial ecology and statistics: a test to compare gene libraries. Appl. Environ. Microbiol. 70: 5485-5492.
DOI
|
21 |
Sorg JA, Sonenshein AL. 2010. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J. Bacteriol. 192: 4983-4990.
DOI
|
22 |
Steele J, Feng H, Parry N, Tzipori S. 2010. Piglet models of acute or chronic Clostridium difficile illness. J. Infect. Dis. 201: 428-434.
DOI
|
23 |
Wang YK, Yan YX, Kim HB, Ju X, Zhao S, Zhang K, et al. 2015. A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters. Hum. Vaccin. Immunother. 11: 2215-2222.
DOI
|
24 |
Zhang Q, Widmer G, Tzipori S. 2013. Apig model of the human gastrointestinal tract. Gut Microbes 4: 193-200.
DOI
|
25 |
Stuck AE, Minder CE, Frey FJ. 1989. Risk of infectious complications in patients taking glucocorticosteroids. Rev. Infect. Dis. 11: 954-963.
DOI
|
26 |
Sun X, Wang H, Zhang Y, Chen K, Davis B, Feng H. 2011. Mouse relapse model of Clostridium difficile infection. Infect. Immun. 79: 2856-2864.
DOI
|